Skip to main content

Animations

MJFF Publications

2481 - 2490 of 8620 Results
Title
Year
  • Year
  • 2008
  • 2013
  • 2018
  • 2013
  • 2017
  • 2008
  • 2011
  • 2009
  • 2007
  • 2018
  • Summary Details
    OPEN
    Title: Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/s1474-4422(08)70117-0
    Citation Count: 1461
  • Summary Details
    OPEN
    Title: Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(13)70210-2
    Citation Count: 261
  • Summary Details
    OPEN
    Title: Hypercholinergic activity in LRRK2 Parkinson's disease
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30073-5
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(13)70293-x
    Best OA location URL:
    Citation Count: 663
  • Summary Details
    OPEN
    Title: Dysregulation of 14‐3‐3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathology
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.421
    Citation Count: 37
  • Summary Details
    OPEN
    Title: A Genome‐wide Scan in an Amish Pedigree with Parkinsonism
    Journal Name: Annals of Human Genetics
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/j.1469-1809.2008.00452.x
    Citation Count: 12
  • Summary Details
    OPEN
    Title: A Genome‐Wide Linkage Screen in the Amish with Parkinson Disease Points to Chromosome 6
    Journal Name: Annals of Human Genetics
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/j.1469-1809.2011.00643.x
    Citation Count: 10
  • Summary Details
    OPEN
    Title: SNCA variants are associated with increased risk for multiple system atrophy
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.21685
    Best OA location URL:
    Citation Count: 273
  • Summary Details
    OPEN
    Title: Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.21157
    Citation Count: 150
  • Summary Details
    OPEN
    Title: Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators
    Journal Name: Molecular Psychiatry
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41380-018-0206-2
    Citation Count: 46
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.